Denali Therapeutics Inc. Basic Shares Outstanding (Weighted Average)
Denali Therapeutics Inc. (DNLI) reported Basic Shares Outstanding (Weighted Average) of 187.31 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- Denali Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 187.31M shares, a 9.25% increase year-over-year.
- Denali Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 186.64M shares, a 9.00% increase year-over-year.
- Denali Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 175.49M shares, a 3.15% increase year-over-year.
- Denali Therapeutics Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 172.42M shares, a 1.75% increase year-over-year.
- Denali Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 172.65M shares, a 4.97% increase from fiscal 2024.
- Denali Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 164.47M shares, a 19.73% increase from fiscal 2023.
- Denali Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 137.37M shares, a 9.43% increase from fiscal 2022.
- Denali Therapeutics Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 125.53M shares, a 3.30% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 187.31M shares 10-Q · filed 2026-08-06 | 186.98M shares 10-Q · filed 2026-08-06 | 183.15M shares derived: average of 3 quarters · filed 2026-08-06 | 180.47M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 186.64M shares 10-Q · filed 2026-05-07 | 181.06M shares derived: average of 2 quarters · filed 2026-05-07 | 178.18M shares derived: average of 3 quarters · filed 2026-05-07 | 176.50M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 175.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 173.96M shares derived: average of 2 quarters · filed 2026-02-26 | 173.12M shares derived: average of 3 quarters · filed 2026-08-06 | 172.65M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 172.42M shares 10-Q · filed 2025-11-06 | 171.94M shares derived: average of 2 quarters · filed 2026-08-06 | 171.70M shares 10-Q · filed 2025-11-06 | 171.31M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 171.45M shares 10-Q · filed 2026-08-06 | 171.34M shares 10-Q · filed 2026-08-06 | 170.93M shares derived: average of 3 quarters · filed 2026-08-06 | 170.56M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 171.22M shares 10-Q · filed 2026-05-07 | 170.67M shares derived: average of 2 quarters · filed 2026-05-07 | 170.27M shares derived: average of 3 quarters · filed 2026-05-07 | 169.91M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 170.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 169.79M shares derived: average of 2 quarters · filed 2026-02-26 | 169.47M shares derived: average of 3 quarters · filed 2026-02-26 | 164.47M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 169.46M shares 10-Q · filed 2025-11-06 | 169.14M shares derived: average of 2 quarters · filed 2025-11-06 | 162.59M shares 10-Q · filed 2025-11-06 | 156.49M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 168.83M shares 10-Q · filed 2025-08-11 | 159.12M shares 10-Q · filed 2025-08-11 | 152.16M shares derived: average of 3 quarters · filed 2026-02-26 | 148.53M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 149.40M shares 10-Q · filed 2025-05-06 | 143.83M shares derived: average of 2 quarters · filed 2026-02-26 | 141.77M shares derived: average of 3 quarters · filed 2026-02-26 | 140.59M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 138.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 137.95M shares derived: average of 2 quarters · filed 2026-02-26 | 137.65M shares derived: average of 3 quarters · filed 2026-02-26 | 137.37M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 137.64M shares 10-Q · filed 2024-11-06 | 137.35M shares derived: average of 2 quarters · filed 2024-11-06 | 137.08M shares 10-Q · filed 2024-11-06 | 136.04M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 137.05M shares 10-Q · filed 2024-08-01 | 136.79M shares 10-Q · filed 2024-08-01 | 135.51M shares derived: average of 3 quarters · filed 2025-02-27 | 132.50M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 136.52M shares 10-Q · filed 2024-05-07 | 134.74M shares derived: average of 2 quarters · filed 2025-02-27 | 130.99M shares derived: average of 3 quarters · filed 2025-02-27 | 128.99M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 132.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 128.22M shares derived: average of 2 quarters · filed 2025-02-27 | 126.48M shares derived: average of 3 quarters · filed 2025-02-27 | 125.53M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 123.47M shares 10-Q · filed 2023-11-07 | 123.24M shares derived: average of 2 quarters · filed 2023-11-07 | 123.05M shares 10-Q · filed 2023-11-07 | 122.83M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | 123.01M shares 10-Q · filed 2023-08-08 | 122.84M shares 10-Q · filed 2023-08-08 | 122.62M shares derived: average of 3 quarters · filed 2024-02-28 | 122.40M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | 122.67M shares 10-Q · filed 2023-05-08 | 122.42M shares derived: average of 2 quarters · filed 2024-02-28 | 122.20M shares derived: average of 3 quarters · filed 2024-02-28 | 121.97M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | 122.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 121.96M shares derived: average of 2 quarters · filed 2024-02-28 | 121.74M shares derived: average of 3 quarters · filed 2024-02-28 | 121.52M shares 10-K · filed 2024-02-28 |
| 2021-09-30 | 121.74M shares 10-Q · filed 2022-11-03 | 121.52M shares derived: average of 2 quarters · filed 2022-11-03 | 121.31M shares 10-Q · filed 2022-11-03 | 121.04M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | 121.29M shares 10-Q · filed 2022-08-08 | 121.09M shares 10-Q · filed 2022-08-08 | 120.81M shares derived: average of 3 quarters · filed 2023-02-27 | 117.48M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | 120.88M shares 10-Q · filed 2022-05-05 | 120.56M shares derived: average of 2 quarters · filed 2023-02-27 | 116.21M shares derived: average of 3 quarters · filed 2023-02-27 | 113.58M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | 120.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | 113.87M shares derived: average of 2 quarters · filed 2023-02-27 | 111.15M shares derived: average of 3 quarters · filed 2023-02-27 | 108.97M shares 10-K · filed 2023-02-27 |
| 2020-09-30 | 107.49M shares 10-Q · filed 2021-11-04 | 106.60M shares derived: average of 2 quarters · filed 2021-11-04 | 105.22M shares 10-Q · filed 2021-11-04 | |
| 2020-06-30 | 105.72M shares 10-Q · filed 2021-08-04 | 104.07M shares 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | 102.42M shares 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | 95.61M shares 10-K · filed 2022-02-28 | |||
| 2018-12-31 | 94.30M shares 10-K · filed 2020-02-27 | 92.62M shares 10-K · filed 2021-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |